Dec 12, 2017 ... According to the Complaint, Impax is a specialty pharmaceutical company ... Transaction”), pursuant to which Impax Laboratories, Inc. (“Impax” or the ... and market status for the underlying securities at issue in the litigation.
Plaintiffs bring this federal securities class action on behalf of a class consisting ..... Lannett Co., Impax Laboratories Inc., Covis Pharma Holdings Sarl, Sun.
Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Impax Laboratories, Inc. securities (NASDAQ: IPXL) ...
The case stems from an action brand manufacturer Endo Pharmaceuticals, Inc. ( Endo) brought against Impax Laboratories, Inc. (Impax) and other generic ...
Apr 5, 2018 ... On April 5, 2018 the U.S. District Court, District of Massachusetts granted preliminary approval to Impax Laboratories Inc.
1”) is part of the prospectus of Amneal Pharmaceuticals, Inc. (the “Company”), dated May 9, 2018 (the “Prospectus”). ... period ended March 31, 2018, as filed with the Securities and Exchange Commission (“SEC”) on May ... (formerly IMPAX LABORATORIES, INC.) ...... In re Generic Pharmaceuticals Pricing Antitrust Litigation.
Sep 8, 2015 ... The FDA notice follows a re-inspection in 2015 by the FDA of the Hayward ... " Safe Harbor" statement under the Private Securities Litigation ...
Defendant: IMPAX LABORATORIES, INC. Plaintiff: .... Nature of Suit: Securities/ Commodities/Exchanges ... In Re: National Prescription Opiate Litigation.
In re Facebook, Inc. IPO Securities and Derivative Litigation: Representation of ... In re Impax Laboratories, Inc. Shareholder Derivative Litigation: Representation ...